Non-Statin Therapies for Lipid Management

Susan Halli-Demeter, RN, DNP, CLS reviews the benefits of non-statin, LDL-C-lowering therapies for patients with very high-risk atherosclerotic cardiovascular disease (ASCVD) and severe hypercholesterolemia.

Read More

2021 Pharmacology Sessions

Clinical management of chronic cardiovascular disease is a key component of the work of advanced practice nurses and RNs in the cardiology and primary care settings. This annual pharmacology CE program was designed to meet the clinical practice and recertification needs of these clinicians. This 2021 curriculum includes a comprehensive approach to pharmacology in: The…

Read More

The 2019 Guideline for Primary Prevention of Cardiovascular Disease

Guideline writing panel member and former PCNA President, Dr. Cheryl Dennison-Himmelfarb provides a timely discussion of the 2019 Guideline for Primary Prevention of CVD with a focus on the role of nurses in applying the Guidelines to clinical practice. This Guideline integrates recent cholesterol, hypertension, and physical activity guidelines and addresses aspirin in primary prevention.

Read More

Case Studies in Cardiovascular Risk Reduction with Non-statin Therapies: Rapid Fire Roundtable

In this rapid-fire roundtable session, Clinical Lipid Specialists Joyce Ross, MSN, CRNP and Dr. Lynne Braun PhD, CNP discuss PCSK9 Inhibitors in practice, including the latest data from CV outcomes studies. They demonstrate how these trials will impact practice through dynamic case studies, including a patient’s with diabetic dyslipidemia, ASCVD, and familial hypercholesterolemia.

Read More